Considering that four hub genes (COL14A1, OGN, MFAP4, and SFRP4) and two key TFs (BNC2 and MEOX2) may serve as potential therapeutic targets of HF, several small-molecule agents targeting hub genes were predicted. This evidence concerns the gene BNC2 and hydrops fetalis.